Rheumatology Research

This listing changes frequently.  For more information about the trials we have available, please contact us at (551) 996-5627 or via e-mail pedsresearch@HackensackUMC.org 

Pro00002091
Jennifer Weiss, MD

PR-COIN (Pediatric Rheumatology-Care and Outcomes Improvement Network)

20120604 / III
Jennifer Weiss, MD

Protocol RA0043:  A Multicenter, Open-Label Study to Assess the Pharmacokinetics, Safety, and Efficacy of Certolizumab Pegol in Children and Adolescents With Moderately to Severely Active Polyarticular-Course Juvenile Idiopathic Arthritis (Pascal Study)

Pro00004906
Jennifer Weiss, MD

Spondyloarthritis Microbiota Study

20140833
Jennifer Weiss, MD

WA29231-Jigsaw Extension Study-Long-Term Extension Study to Evaluate the Safety and Efficacy of Subcutaneous Tocilizumab in Patients With Polyarticular Course and Systemic Juvenile Idiopathic Arthritis

Pro00005464 / III
Jennifer Weiss, MD

A Multicenter, Open-Label Trial of Intravenous Golimumab, a Human Anti-TNF Alpha Antibody, in Pediatric Subjects With Active Polyarticular Course Juvenile Idiopathic Arthritis Despite Methotrexate Therapy

Pro00005835
Jennifer Weiss, MD

Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry

07.02.055 / IV
Suzanne Li, MD

Development of Clinical and Ultrasound Measures for Pediatric Localized Scleroderma-Locus 2

Pro00002284 / IV
Suzanne Li, MD

Evaluating Quality of Life in Pediatric Rheumatology Patients

06.02.118
Suzanne Li, MD

A Project Towards Establishment of a US/Canadian Diagnostic Registry of Children With Chronic Vasculitis (ARCHIVE, A Registry for Children With Vasculitis: e-entry) (Peds Vasculitis)

20122020 / II
Suzanne Li, MD

A Phase IIa, International, Multicenter, Open-Label, Uncontrolled Study to Evaluate the Safety and Pharmacokinetics of 4 x 375 mg/m2 Intravenous Rituximab in Pediatric Patients With SEVERE Granulomatosis With Polyangiitis (Wegener’s) and Microscopic Polyangiitis (Rituximab-Vasculitis)

Pro00004269
Yukiko Kimura, MD

The Learning Cohort (TLC): BCH R01 Overview-Carra Registry Substudy

20111760 / I
Yukiko Kimura, MD

A Phase I Pharmacokinetic and Safety Study of Tocilizumab (TCZ) in Patients Less Than 2 Years Old With Active Systemic Juvenile Idiopathic Arthritis (sJIA) (NP25737)

Pro00003867
Kathleen Haines, MD

A Registry of Patients With Primary Immunodeficiency Disorder

20130533 / I
Ginger Janow, MD

A Phase Ib, Open-Label, Multicenter Study to Investigate the Pharmacokinetics, Pharmacodynamics, and Safety of Tocilizumab Following Subcutaneous Administration to Patients With Polyarticular-Course Juvenile  Idiopathic Arthritis WA28117

20130534 / I
Ginger Janow, MD

A Phase Ib, Open-Label, Multicenter Study to Investigate the Pharmacokinetics, Pharmacodynamics, and Safety of Tocilizumab Following Subcutaneous Administration to Patients With Systemic Juvenile Idiopathic Arthritis WA28118

 

 


close (X)